Pricing Log in Create free account

Jaguar Animal Health, Inc. (JAGX) vs Heatwurx Inc. (PCSA)

Jaguar Animal Health, Inc. and Heatwurx Inc. are both Biotechnology companies. Heatwurx Inc. is the larger, with a market value of $5.2M against $4.2M — 1.2× the size. Jaguar Animal Health, Inc. trades at the lower P/E: 0.0× against 1.8×. Jaguar Animal Health, Inc. grew revenue faster over the last twelve months: 135.5% against −34.5%. Heatwurx Inc. has the higher net margin (0.00% vs −188.5%) and the higher return on invested capital (0.00% vs −28,393.6%). Across the 17 metrics below, Heatwurx Inc. leads on 9 and Jaguar Animal Health, Inc. on 8.

Valuation

Metric JAGX PCSA Biotechnology median
P/E 0.00 1.75 8.58
P/S 0.00 38.64 10.29
P/B 0.02 n/m 2.29
Price to free cash flow n/m n/m 21.93
EV/EBITDA 0.14 n/m 0.67
EV/Sales (0.11) 48.44 9.89
Earnings yield 82,577.65% 57.14% (31.56%)
Free cash flow yield (6,233.72%) (259.68%) (23.42%)

Profitability

Metric JAGX PCSA Biotechnology median
Gross margin 82.31% 0.00% 65.77%
Operating margin (93.10%) 0.00% 0.00%
Net margin (188.46%) 0.00% 0.00%
Free cash flow margin (24.03%) 0.00% 0.00%
Return on equity (1,125.38%) (464.19%) (54.09%)
Return on assets (127.14%) (262.17%) (47.78%)
Return on invested capital (28,393.64%) 0.00% 0.00%

Growth

Metric JAGX PCSA Biotechnology median
Revenue growth (TTM) 135.52% (34.50%) 5.83%
EPS growth (last fiscal year) 82.42% 89.29% 29.36%
Revenue growth, 5-year CAGR 4.17% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JAGX PCSA Biotechnology median
Debt to equity 0.35 0.00 0.00
Current ratio 0.69 0.87 4.80
Net debt to EBITDA (0.17) 0.40 0.97

Dividend

Metric JAGX PCSA Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric JAGX PCSA Biotechnology median
Market cap 4.18m 5.20m 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack